{
{
{
},
“volumeNumber”: “284”
}
},
{
{
},
{
}
],
},
},
{
},
“issueNumber”: “17(9)”
},
},
{
}
},
{
},
“issueNumber”: “29(1_suppl)”
}
},
{
},
“volumeNumber”: “32”
}
},
{
},
{
},
{
}
]
}
]
}
]
}

Selected Academic, Research & Project Experience – Posters & Publications

Knowledge Augmented Graph Reasoner (KAGR): A Neuro-Symbolic Approach to Instruction Adherence in Healthcare AI

Proceedings of Machine Learning Research vol 284:1–4, 2025. 19th Conference on Neurosymbolic Learning and Reasoning.

Navigating the Diagnostic and Treatment Odyssey of Patients with Genetic Diseases

Mixed methods project to improve genomic medicine services, 2025.

Direct-to-Consumer Genomic Testing: Position Statement

British Society for Genetic Medicine, Royal College of General Practitioners, Royal Pharmaceutical Society, British Pharmacological Society, UK Clinical Pharmacy Association. September 2025. London: BSGM, 2025.

Role: reviewer and representing UKCPA and GMSA views.

Identifying and Evaluating Chrono-Pharmacogenomic Variants

MSt Genomic Medicine – University of Cambridge. Pharmacogenomics – utilising several bioinformatics tools and databases to demonstrate proof of novel concept of next generation of precision medicine. Collaboration with lab members. Three drafts in progress for submission to peer-review.

• Poster presented at European Society of Human Genetics 2023
• Abstract published European Journal of Human Genetics – 2024
• Full publication in progress exp. 2025.

Understanding and Managing Common Drug Interactions

Saoulidis A, Micallef C (2022). Nursing Standard. doi: 10.7748/ns.2022.e11806. Role: Lead author.

STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS Guideline

Chaplin M, Kirkham JJ, Dwan K, Sloan DJ, Davies G, et al. (2020). PLOS Medicine 17(9): e1003344. https://doi.org/10.1371/journal.pmed.1003344.

Role: Contribution to both rounds of expert DELPHI panel – my name is in the acknowledgements.

Posters & Conference Abstracts

• AI with Guardrails for Pharmacogenomics (PGx). Guideline-anchored, explainable conversational recommendations powered by a knowledge-graph controller. Pharmacogenomics Global Research Network, Montana, US, 2025
• A service evaluation of potential workload from implementing pharmacogenomics testing at Cambridge University Hospitals NHS FT. Festival of Genomics 2023 and UKCPA Conference 2023 (Best Poster Award). Lead Author: Paul Selby
• Pharmacy Genomics Workforce Round Table – examining & discussing workforce needs to inform a national strategy. Clinical Pharmacy Congress 2023
• Learning from the implementation of DPYD pharmacogenetic testing across 18 acute NHS Trusts. Festival of Genomics 2023
• DPYD pharmacogenomic testing – What do patients want to know? Festival of Genomics 2023
• Retrospective UK analysis of dihydropyrimidine dehydrogenase (DPYD) gene testing, toxicity and ethnicity for patients receiving Fluoropyrimidines (5-fluorouracil, capecitabine and tegafur). BOPA 2022 – Abstract 48
• An evaluation of Clostridioides difficile infection and treatment outcomes using fidaxomicin at Cambridge University Hospitals. Federation of Infection Societies Conference, Manchester, 2021
• Pharmacist prescribing breadth and error rate. UKCPA Pharman 2018 (Best Poster Award)

Other Publications & Media

• Genomics in Pharmacy – NHS England Genomics Education. Pharmacy landing page website. Lead developer, 2024. Genomics Education Programme
• Pharmacy’s guide to genomic medicine. RxMagazine – Development resources, 2023. UKCPA
• Pharmacy & genomics workforce videos – 4 hours of educational media designed for senior pharmacy leaders. NHS England, 2022
• Introduction to genomics in pharmacy module – Centre for Postgraduate Pharmacy Education, 2020 (subject matter expert)
• Pharmacy professionals and Genomic Medicine – Royal Pharmaceutical Society Expert Advisory Group, 2023
• Nurse’s guide on understanding and managing drug-drug interactions. RCNi Nursing Standard, July 2022
• Addressing barriers to early identification, genetic testing and diagnosis, and inclusion in trials for alkaptonuria patients. Alkaptonuria Society & Cambridge Consulting Network, 2021
• Pharmacy genomics workforce, education and training strategic framework – NHS England, 2024 (indirect contribution)

Work in Progress

• UKCPA Pharmacogenomics handbook (exp. 2026)
• CERSI-PGx guideline for clopidogrel pharmacogenetics (exp. 2026)
• Royal Pharmaceutical Society Prescribing Framework update (exp. 2026) for pharmacogenomics
• Chrono-Pharmacogenomics: Integrating Circadian Biology with Personalised Medicine
• Identification and evaluation of chrono-pharmacogenomic variants to computationally identify drugs and pharmacological pathways with chrono-dosing potential
• Drugging the clock – identification of patients with chronopharmacogenomic variants in the 100k genome patient cohort
• Review of Large Language Models in pharmacogenomic and systemic anticancer treatment counselling for patients
• Implementation of a pharmacogenomics AI assistant in a large teaching hospital

MPharm Research Projects

• Comparative modelling of animal isoforms of cytochromes P450 as a starting point for computational models to determine human-specific metabolites. Various cheminformatic tools and resources evaluated against accepted quality standards.
• Predicting percutaneous drug permeability using computational neural networks. Summer research internship requiring autonomous learning to curate a vast database and derive a research conclusion through machine learning.

{
    {
    },
    {
    },
    {
    },
    {
    },
    {
    },
    {
    },
    {
    }
  ]
}

📋 LLMS · LLMS Full